Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 37 | 2024 | 4215 | 3.160 |
Why?
|
Liver Transplantation | 30 | 2023 | 2325 | 2.040 |
Why?
|
Hepatitis C | 8 | 2021 | 1579 | 1.360 |
Why?
|
Kidney Failure, Chronic | 14 | 2024 | 2471 | 1.230 |
Why?
|
Portal Vein | 4 | 2013 | 429 | 1.060 |
Why?
|
Hyperoxaluria, Primary | 3 | 2017 | 24 | 1.030 |
Why?
|
Tissue Donors | 19 | 2024 | 2313 | 1.010 |
Why?
|
Tissue and Organ Procurement | 8 | 2024 | 944 | 0.980 |
Why?
|
Donor Selection | 4 | 2023 | 228 | 0.960 |
Why?
|
Hepatitis C, Chronic | 7 | 2021 | 1031 | 0.860 |
Why?
|
Hepacivirus | 9 | 2021 | 1334 | 0.840 |
Why?
|
BK Virus | 5 | 2021 | 123 | 0.780 |
Why?
|
Kidney Diseases | 3 | 2020 | 2093 | 0.670 |
Why?
|
Polyomavirus Infections | 4 | 2021 | 194 | 0.630 |
Why?
|
Renal Dialysis | 6 | 2021 | 1801 | 0.620 |
Why?
|
Tumor Virus Infections | 4 | 2021 | 438 | 0.590 |
Why?
|
Hepatitis B | 3 | 2021 | 701 | 0.580 |
Why?
|
Living Donors | 9 | 2023 | 636 | 0.570 |
Why?
|
Graft Survival | 17 | 2024 | 3794 | 0.560 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2020 | 800 | 0.510 |
Why?
|
Antiviral Agents | 8 | 2021 | 3061 | 0.500 |
Why?
|
Carcinoma, Hepatocellular | 7 | 2023 | 2299 | 0.480 |
Why?
|
Embolization, Therapeutic | 2 | 2013 | 1413 | 0.450 |
Why?
|
Liver Neoplasms | 7 | 2023 | 4319 | 0.380 |
Why?
|
Transplantation Tolerance | 1 | 2015 | 605 | 0.350 |
Why?
|
Liver Failure, Acute | 3 | 2018 | 181 | 0.350 |
Why?
|
Transplantation, Heterologous | 6 | 2017 | 2379 | 0.320 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2315 | 0.320 |
Why?
|
Hepatopulmonary Syndrome | 1 | 2008 | 24 | 0.300 |
Why?
|
Blood Coagulation Factors | 5 | 2017 | 365 | 0.300 |
Why?
|
Liver Failure | 2 | 2018 | 249 | 0.270 |
Why?
|
Transplantation, Homologous | 5 | 2022 | 4810 | 0.260 |
Why?
|
End Stage Liver Disease | 3 | 2023 | 353 | 0.260 |
Why?
|
Anticoagulants | 1 | 2021 | 4897 | 0.250 |
Why?
|
Kidney Neoplasms | 2 | 2020 | 4312 | 0.250 |
Why?
|
Oxalates | 2 | 2017 | 98 | 0.250 |
Why?
|
Organ Transplantation | 4 | 2022 | 1150 | 0.220 |
Why?
|
Pancreas Transplantation | 1 | 2024 | 196 | 0.220 |
Why?
|
HIV Infections | 7 | 2024 | 17165 | 0.200 |
Why?
|
Graft Rejection | 7 | 2024 | 4426 | 0.200 |
Why?
|
Humans | 82 | 2024 | 760621 | 0.200 |
Why?
|
Postoperative Hemorrhage | 3 | 2014 | 422 | 0.190 |
Why?
|
Quinoxalines | 2 | 2020 | 297 | 0.190 |
Why?
|
Liver | 9 | 2023 | 7509 | 0.190 |
Why?
|
Hepatectomy | 3 | 2020 | 559 | 0.190 |
Why?
|
Retrospective Studies | 27 | 2023 | 80372 | 0.190 |
Why?
|
Liver Cirrhosis | 4 | 2023 | 1931 | 0.180 |
Why?
|
Aminoisobutyric Acids | 1 | 2020 | 39 | 0.180 |
Why?
|
Kidney | 7 | 2023 | 7064 | 0.180 |
Why?
|
Hepatitis B virus | 2 | 2021 | 522 | 0.180 |
Why?
|
Swine, Miniature | 4 | 2018 | 959 | 0.180 |
Why?
|
Organ Preservation | 1 | 2023 | 379 | 0.170 |
Why?
|
Splenorenal Shunt, Surgical | 1 | 2019 | 14 | 0.170 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2004 | 733 | 0.170 |
Why?
|
Perfusion | 2 | 2023 | 1376 | 0.160 |
Why?
|
Cyclopropanes | 1 | 2020 | 431 | 0.160 |
Why?
|
Leucine | 1 | 2020 | 547 | 0.160 |
Why?
|
Lactams, Macrocyclic | 1 | 2020 | 315 | 0.160 |
Why?
|
Proline | 1 | 2020 | 457 | 0.160 |
Why?
|
Heat Stroke | 1 | 2018 | 29 | 0.160 |
Why?
|
Disease Transmission, Infectious | 2 | 2017 | 558 | 0.150 |
Why?
|
Benzimidazoles | 2 | 2020 | 858 | 0.150 |
Why?
|
Papio | 5 | 2018 | 661 | 0.150 |
Why?
|
Galactosyltransferases | 3 | 2018 | 276 | 0.150 |
Why?
|
Male | 46 | 2024 | 359744 | 0.150 |
Why?
|
Lymph Node Excision | 1 | 2004 | 1303 | 0.150 |
Why?
|
Aftercare | 1 | 2023 | 916 | 0.140 |
Why?
|
Nephrectomy | 4 | 2017 | 1016 | 0.140 |
Why?
|
Liver Regeneration | 1 | 2018 | 213 | 0.140 |
Why?
|
Middle Aged | 36 | 2024 | 220352 | 0.140 |
Why?
|
Papio hamadryas | 2 | 2013 | 31 | 0.140 |
Why?
|
Esophageal and Gastric Varices | 1 | 2019 | 208 | 0.140 |
Why?
|
Hypertension, Portal | 1 | 2019 | 226 | 0.140 |
Why?
|
Hepatolenticular Degeneration | 1 | 2017 | 72 | 0.140 |
Why?
|
HIV Seropositivity | 1 | 2022 | 955 | 0.140 |
Why?
|
Immunosuppressive Agents | 4 | 2017 | 4166 | 0.140 |
Why?
|
Adrenal Glands | 1 | 2019 | 554 | 0.140 |
Why?
|
Urologic Neoplasms | 1 | 2020 | 320 | 0.130 |
Why?
|
Waiting Lists | 4 | 2024 | 763 | 0.130 |
Why?
|
Brain Death | 3 | 2023 | 356 | 0.130 |
Why?
|
Swine | 9 | 2018 | 5899 | 0.120 |
Why?
|
Adult | 31 | 2024 | 219994 | 0.120 |
Why?
|
Veins | 1 | 2019 | 765 | 0.120 |
Why?
|
Transplantation Chimera | 2 | 2015 | 595 | 0.120 |
Why?
|
Death | 2 | 2010 | 678 | 0.120 |
Why?
|
Ribavirin | 1 | 2016 | 396 | 0.120 |
Why?
|
Animals, Genetically Modified | 5 | 2018 | 1553 | 0.120 |
Why?
|
Survival Rate | 7 | 2020 | 12808 | 0.120 |
Why?
|
Motivation | 1 | 2024 | 1993 | 0.120 |
Why?
|
Postoperative Complications | 8 | 2024 | 15697 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1182 | 0.110 |
Why?
|
Female | 42 | 2024 | 391270 | 0.110 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2019 | 1131 | 0.110 |
Why?
|
Sulfonamides | 2 | 2020 | 1977 | 0.110 |
Why?
|
Antibodies, Heterophile | 1 | 2013 | 128 | 0.110 |
Why?
|
Thrombocytopenia | 3 | 2016 | 1174 | 0.110 |
Why?
|
Ureterostomy | 1 | 2012 | 18 | 0.100 |
Why?
|
Weight Loss | 1 | 2024 | 2686 | 0.100 |
Why?
|
Informed Consent | 1 | 2019 | 1005 | 0.100 |
Why?
|
Cystostomy | 1 | 2012 | 25 | 0.100 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2016 | 294 | 0.100 |
Why?
|
Protein S Deficiency | 1 | 2011 | 13 | 0.100 |
Why?
|
Hypertension, Malignant | 1 | 2012 | 17 | 0.100 |
Why?
|
Pneumatosis Cystoides Intestinalis | 1 | 2012 | 31 | 0.100 |
Why?
|
RNA, Viral | 1 | 2020 | 2838 | 0.100 |
Why?
|
Immunoglobulin G | 2 | 2014 | 4541 | 0.100 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1741 | 0.100 |
Why?
|
Aged | 18 | 2024 | 169152 | 0.090 |
Why?
|
Polytetrafluoroethylene | 2 | 2011 | 245 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2014 | 4353 | 0.090 |
Why?
|
Bile Ducts | 1 | 2011 | 282 | 0.090 |
Why?
|
Mesentery | 1 | 2011 | 202 | 0.090 |
Why?
|
Creatinine | 2 | 2013 | 1903 | 0.090 |
Why?
|
Hemostasis | 2 | 2023 | 468 | 0.090 |
Why?
|
Treatment Outcome | 15 | 2022 | 65017 | 0.090 |
Why?
|
Ureter | 1 | 2012 | 375 | 0.080 |
Why?
|
Carcinoid Tumor | 1 | 2011 | 228 | 0.080 |
Why?
|
Thrombosis | 1 | 2023 | 3052 | 0.080 |
Why?
|
Hematoma | 1 | 2013 | 769 | 0.080 |
Why?
|
Cecum | 1 | 2009 | 232 | 0.080 |
Why?
|
Schistosomiasis mansoni | 1 | 2009 | 94 | 0.080 |
Why?
|
Lymphocele | 1 | 2008 | 19 | 0.080 |
Why?
|
Patient Selection | 4 | 2016 | 4283 | 0.080 |
Why?
|
Virus Integration | 2 | 2020 | 302 | 0.080 |
Why?
|
Schistosoma mansoni | 1 | 2009 | 156 | 0.080 |
Why?
|
Pyrrolidines | 2 | 2020 | 340 | 0.080 |
Why?
|
Gene Knockout Techniques | 3 | 2018 | 802 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3616 | 0.070 |
Why?
|
Constriction, Pathologic | 1 | 2011 | 1098 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2020 | 2276 | 0.070 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2014 | 1355 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2019 | 1895 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2013 | 4550 | 0.070 |
Why?
|
Blood Vessel Prosthesis | 2 | 2011 | 956 | 0.070 |
Why?
|
Biopsy | 4 | 2013 | 6771 | 0.070 |
Why?
|
Body Mass Index | 1 | 2024 | 12914 | 0.070 |
Why?
|
Coccidioides | 1 | 2006 | 18 | 0.070 |
Why?
|
Heart | 1 | 2019 | 4393 | 0.070 |
Why?
|
Social Class | 1 | 2015 | 2005 | 0.070 |
Why?
|
Coccidioidomycosis | 1 | 2006 | 37 | 0.070 |
Why?
|
Risk Factors | 7 | 2023 | 74359 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2016 | 1446 | 0.060 |
Why?
|
Bone Marrow Transplantation | 1 | 2013 | 2693 | 0.060 |
Why?
|
Virus Replication | 1 | 2013 | 2432 | 0.060 |
Why?
|
Heart Transplantation | 1 | 2019 | 3224 | 0.060 |
Why?
|
Lymphoma, T-Cell | 1 | 2008 | 305 | 0.060 |
Why?
|
Melanoma | 1 | 2004 | 5697 | 0.060 |
Why?
|
HIV-1 | 1 | 2022 | 6849 | 0.060 |
Why?
|
Vascular Patency | 3 | 2016 | 901 | 0.060 |
Why?
|
Tissue and Organ Harvesting | 1 | 2008 | 377 | 0.060 |
Why?
|
Graft Occlusion, Vascular | 1 | 2008 | 560 | 0.060 |
Why?
|
Liver Function Tests | 3 | 2017 | 524 | 0.060 |
Why?
|
Prognosis | 6 | 2020 | 29658 | 0.060 |
Why?
|
Intestines | 2 | 2011 | 1907 | 0.060 |
Why?
|
Prospective Studies | 8 | 2023 | 54303 | 0.060 |
Why?
|
United States | 3 | 2022 | 72461 | 0.060 |
Why?
|
Hypercholesterolemia | 1 | 2011 | 1155 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2004 | 5799 | 0.060 |
Why?
|
Peritoneal Neoplasms | 1 | 2011 | 707 | 0.060 |
Why?
|
Drug Combinations | 2 | 2020 | 2025 | 0.060 |
Why?
|
Lymphatic Vessels | 1 | 2008 | 358 | 0.060 |
Why?
|
Hemorrhage | 1 | 2016 | 3600 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8469 | 0.060 |
Why?
|
Hepatic Encephalopathy | 2 | 2012 | 144 | 0.050 |
Why?
|
HIV | 2 | 2022 | 1579 | 0.050 |
Why?
|
Isoantibodies | 1 | 2006 | 661 | 0.050 |
Why?
|
Radiographic Image Enhancement | 1 | 2007 | 875 | 0.050 |
Why?
|
Follow-Up Studies | 7 | 2021 | 39261 | 0.050 |
Why?
|
Hemostatic Disorders | 1 | 2002 | 3 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1135 | 0.050 |
Why?
|
Antigens, CD | 2 | 2013 | 4000 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8552 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4742 | 0.050 |
Why?
|
Proviruses | 1 | 2022 | 313 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9276 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5649 | 0.050 |
Why?
|
Fatal Outcome | 3 | 2012 | 1832 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2007 | 1403 | 0.050 |
Why?
|
Bone Marrow Cells | 1 | 2008 | 2414 | 0.040 |
Why?
|
Antigens, Viral, Tumor | 1 | 2020 | 153 | 0.040 |
Why?
|
Chromosome Breakage | 1 | 2020 | 159 | 0.040 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2180 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2010 | 2001 | 0.040 |
Why?
|
Animals | 12 | 2018 | 167963 | 0.040 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 2013 | 516 | 0.040 |
Why?
|
Diagnosis, Differential | 5 | 2017 | 12965 | 0.040 |
Why?
|
Integrases | 1 | 2022 | 516 | 0.040 |
Why?
|
Virus Latency | 1 | 2022 | 362 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8056 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6828 | 0.040 |
Why?
|
Serologic Tests | 2 | 2017 | 383 | 0.040 |
Why?
|
Transplantation, Heterotopic | 1 | 2018 | 174 | 0.040 |
Why?
|
Blood Coagulation Disorders | 1 | 2002 | 349 | 0.040 |
Why?
|
Viremia | 1 | 2021 | 707 | 0.040 |
Why?
|
Cholecystitis | 1 | 1999 | 181 | 0.040 |
Why?
|
Apoptosis | 1 | 2014 | 9501 | 0.040 |
Why?
|
Young Adult | 3 | 2019 | 58741 | 0.040 |
Why?
|
Pancreas | 1 | 2024 | 1677 | 0.040 |
Why?
|
Immune Sera | 1 | 1997 | 613 | 0.040 |
Why?
|
Pilot Projects | 2 | 2021 | 8555 | 0.040 |
Why?
|
Hyperoxaluria | 1 | 2017 | 32 | 0.040 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 1999 | 231 | 0.040 |
Why?
|
Genome, Viral | 1 | 2020 | 658 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 3 | 2016 | 6544 | 0.030 |
Why?
|
Jaundice | 1 | 2017 | 97 | 0.030 |
Why?
|
Counseling | 1 | 2024 | 1548 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2002 | 1157 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2017 | 956 | 0.030 |
Why?
|
Reoperation | 2 | 2018 | 4291 | 0.030 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2017 | 330 | 0.030 |
Why?
|
Immunization, Passive | 1 | 1997 | 616 | 0.030 |
Why?
|
Immunity, Cellular | 2 | 2013 | 1557 | 0.030 |
Why?
|
Time Factors | 6 | 2016 | 40165 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 465 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2421 | 0.030 |
Why?
|
Health Care Costs | 1 | 2007 | 3258 | 0.030 |
Why?
|
Hospitals, Pediatric | 1 | 2023 | 1854 | 0.030 |
Why?
|
Bilirubin | 2 | 2011 | 438 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 2017 | 300 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2010 | 11152 | 0.030 |
Why?
|
Comorbidity | 2 | 2021 | 10551 | 0.030 |
Why?
|
Antigens, CD20 | 1 | 2014 | 201 | 0.030 |
Why?
|
Cyclosporine | 1 | 1996 | 777 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 3804 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2022 | 2536 | 0.030 |
Why?
|
Interferon-alpha | 1 | 1997 | 918 | 0.030 |
Why?
|
Viral Load | 1 | 2022 | 3322 | 0.030 |
Why?
|
Acetaminophen | 1 | 2017 | 553 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2014 | 736 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2022 | 1779 | 0.030 |
Why?
|
Transplantation Conditioning | 1 | 2019 | 1588 | 0.030 |
Why?
|
Protein S | 1 | 2011 | 30 | 0.030 |
Why?
|
Child | 4 | 2023 | 79806 | 0.020 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2011 | 65 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2012 | 20509 | 0.020 |
Why?
|
Geography | 1 | 2013 | 661 | 0.020 |
Why?
|
Delayed Graft Function | 1 | 2011 | 49 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2017 | 820 | 0.020 |
Why?
|
Biliary Tract Diseases | 1 | 2011 | 157 | 0.020 |
Why?
|
Abdomen | 1 | 2017 | 1130 | 0.020 |
Why?
|
Hemostasis, Surgical | 1 | 2011 | 129 | 0.020 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 356 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3476 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2024 | 3527 | 0.020 |
Why?
|
Mutation | 1 | 2014 | 29932 | 0.020 |
Why?
|
Aging | 1 | 2008 | 8651 | 0.020 |
Why?
|
Intracranial Pressure | 1 | 2012 | 325 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3465 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3455 | 0.020 |
Why?
|
Child, Preschool | 2 | 2013 | 42063 | 0.020 |
Why?
|
Intracranial Hypertension | 1 | 2012 | 193 | 0.020 |
Why?
|
Hepatitis, Autoimmune | 1 | 2011 | 172 | 0.020 |
Why?
|
Hemodynamics | 1 | 2019 | 4174 | 0.020 |
Why?
|
Life Expectancy | 1 | 2016 | 1248 | 0.020 |
Why?
|
Postoperative Period | 1 | 2013 | 1818 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2011 | 865 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2011 | 351 | 0.020 |
Why?
|
Liver Diseases | 1 | 2017 | 1302 | 0.020 |
Why?
|
Endemic Diseases | 1 | 2009 | 190 | 0.020 |
Why?
|
Exercise | 1 | 2024 | 5787 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2014 | 1328 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4417 | 0.020 |
Why?
|
Splenomegaly | 1 | 2008 | 189 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2013 | 1411 | 0.020 |
Why?
|
Pancytopenia | 1 | 2008 | 101 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 2011 | 434 | 0.020 |
Why?
|
Quality Improvement | 1 | 2022 | 3836 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 7475 | 0.020 |
Why?
|
Laparoscopy | 2 | 2009 | 2147 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2008 | 345 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6498 | 0.020 |
Why?
|
Diagnosis-Related Groups | 1 | 2007 | 450 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2011 | 2116 | 0.020 |
Why?
|
Coma | 1 | 2009 | 487 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 2012 | 942 | 0.020 |
Why?
|
Resource Allocation | 1 | 2007 | 349 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2023 | 15840 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4642 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1997 | 4433 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 2006 | 900 | 0.010 |
Why?
|
Hematologic Diseases | 1 | 2008 | 496 | 0.010 |
Why?
|
Cadaver | 1 | 2008 | 1345 | 0.010 |
Why?
|
Angiography | 1 | 2009 | 1605 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9716 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2014 | 2725 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2013 | 5870 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9280 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2011 | 1689 | 0.010 |
Why?
|
Radiology Information Systems | 1 | 2007 | 528 | 0.010 |
Why?
|
New England | 1 | 2006 | 1050 | 0.010 |
Why?
|
Emigrants and Immigrants | 1 | 2009 | 539 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2014 | 18957 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21392 | 0.010 |
Why?
|
Drainage | 1 | 2008 | 1161 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 12922 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2008 | 1063 | 0.010 |
Why?
|
Adolescent | 3 | 2017 | 87810 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13314 | 0.010 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 1215 | 0.010 |
Why?
|
Fever | 1 | 2008 | 1617 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 5961 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 8035 | 0.010 |
Why?
|
Models, Animal | 1 | 2006 | 2117 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2006 | 1827 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18137 | 0.010 |
Why?
|
Platelet Count | 1 | 2002 | 777 | 0.010 |
Why?
|
Heart Arrest | 1 | 2009 | 1506 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18416 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2006 | 1784 | 0.010 |
Why?
|
Brain Injuries | 1 | 2010 | 2044 | 0.010 |
Why?
|
Complement System Proteins | 1 | 2002 | 782 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2006 | 2299 | 0.010 |
Why?
|
Dogs | 1 | 2002 | 3841 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7850 | 0.010 |
Why?
|
Complement C4 | 1 | 1997 | 244 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2013 | 5397 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22053 | 0.010 |
Why?
|
Phenotype | 1 | 2013 | 16546 | 0.010 |
Why?
|
Complement C3 | 1 | 1997 | 451 | 0.010 |
Why?
|
Aspartate Aminotransferases | 1 | 1996 | 416 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2007 | 5508 | 0.010 |
Why?
|
Endothelium | 1 | 1997 | 764 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 1996 | 606 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14660 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 15289 | 0.010 |
Why?
|
Postoperative Care | 1 | 1997 | 1479 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2016 | 58995 | 0.010 |
Why?
|
Kinetics | 1 | 1997 | 6377 | 0.010 |
Why?
|
Aorta | 1 | 1997 | 2039 | 0.010 |
Why?
|
Preoperative Care | 1 | 1997 | 2256 | 0.000 |
Why?
|
Acute Disease | 1 | 1999 | 7269 | 0.000 |
Why?
|
Analysis of Variance | 1 | 1997 | 6238 | 0.000 |
Why?
|
Risk Assessment | 1 | 2009 | 24123 | 0.000 |
Why?
|
Cholesterol | 1 | 1996 | 2924 | 0.000 |
Why?
|
Cell Survival | 1 | 1997 | 5797 | 0.000 |
Why?
|
Length of Stay | 1 | 1999 | 6479 | 0.000 |
Why?
|
Recurrence | 1 | 1997 | 8482 | 0.000 |
Why?
|
Blood Glucose | 1 | 1996 | 6381 | 0.000 |
Why?
|
Neoplasms | 1 | 2008 | 22072 | 0.000 |
Why?
|
Brain | 1 | 2006 | 26951 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2006 | 36290 | 0.000 |
Why?
|